Helicobacter pylori: Novel therapies

Canadian Journal of Gastroenterology

Volumn 13, Issue 7, 1999, Pages 581-583

  Drouin, Eric ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Helicobacter pylori; Neutriceuticals; Pediatrics; Probiotics

Indexed keywords

12 SULFODEHYDROABIETIC ACID; AMOXICILLIN; ANTIULCER AGENT; AZITHROMYCIN; BISMUTH CITRATE; CAPSAICIN; EBROTIDINE; FURAZOLIDONE; GARLIC EXTRACT; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; LACTOFERRIN; OLIGOSACCHARIDE; OMEPRAZOLE; PLANOTOL; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; QUINOLONE; RABEPRAZOLE; SUCRALFATE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBIOTIC RESISTANCE; CHILD; CONFERENCE PAPER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFANT; LACTOBACILLUS; NUTRIENT; PATIENT COMPLIANCE; PEDIATRICS; PRIORITY JOURNAL;

EID: 0032825021     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/485237     Document Type: Conference Paper

References (18)

1. Vandenplas Y, Blecker U. Helicobacter pylori infection in children. Acta Paediatr 1998;87:1105-12.
2. Montague S, O'Morain C. Novel Therapies for Helicobacter pylori Eradication. Helicobacter pylori: Basic Mechanisms to Clinical Cure 1998. Dordrecht: Kluwer Academic Publishers, 1998:441-55.
3. Howden A, Boswell P, Tovey F. In-vitro sensitivity of Campylobacter pyloridis to furazolidone. Lancet 1986;ii:1035.
4. Segura AM, Gutierrez O, Otero W, Angel A, Oenta RM, Graham DY. Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11:529-32.
5. Van Zwet AA, Thijs JC, van der Wouden EJ, Kooy A. Low cure rate of Helicobacter pylori infection with omeprazole and furazolidone dual therapy for one week. Aliment Pharmacol Ther 1997;11:533-5.
6. Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996;91:258-63.
7. Di Mario F, Dal Bo N, Grassi SA, et al. Azithromycin for the cure of Helicobacter pylori infection. Am J Gastroenterol 1996;91:264-7.
8. Lamargue D, Tankovic J, Benhouma A, Sevin E, Delchier AJC. Triple therapy using ciprofloxacin for eradication of clarithromycin and metronidazole resistant H. pylori. Gut 1997(Suppl 1):A09/383. (Abst)
9. Stack WA, Knifton A, Jenkins D, et al. Rabeprazole is effective and safe when used in combination with antibiotics for the eradication of Helicobacter pylori. Gut 1997;41(Suppl 3):74. (Abst)
10. Palacin C, Tarrago C, Sacristan A, Ortiz JA. In vitro anti-Helicobacter pylori activity of ebrotidine. Arzneimittelforschung 1997;47:471-4.
11. Popiela T, Kulig J, Karcz D, et al. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer. Arzneimittelforschung 1997;47:573-7.
12. al Somal N, Coley KE, Molan PC, Hancock BM. Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey. J R Soc Med 1994;87:9-12.
13. Osato MS, Reddy SG, Graham DY. Osmotic effect of honey on growth and viability of Helicobacter pylori. Dig Dis Sci 1999;44:462-4.
14. Jones NL, Shabib S, Sherman PM. Capsaicin as an inhibitor of the growth of the gastric pathogen Helicobacter pylori. FEMS Microbiol Lett 1997;146:223-7.
15. Sivam GP, Lampe JW, Ulness B, Swanzy SR, Potter JD. Helicobacter pylori - in vitro susceptibility to garlic (Affium sarivum) extract. Nutr Cancer 1997;27:118-21.
16. Germano MP, Sanogo R, Guglielmo M, De Pasquale R, Crisafi G, Bisignano G. Effects of Pteleopsis suberosa extracts on experimental gastric ulcers and Helicobacter pylori growth. J Ethnopharmacol 1998;59:167-72.
17. Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut 1997;41:49-55.
18. Opekun AR, El-Zaimaity HM, Osato MS, et al. Novel therapies for Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:35-42.